Major insurer partners with private equity firm for care coordination

Insurance giant Elevance Health entered into an agreement with private equity firm Clayton, Dubilier & Rice (CD&R), specifically its healthcare companies Apree Health and Millennium Physician Group (MPG).

In an announcement, Elevance said the move aims to expand patient access to primary care services for its Carelon Health patients. Through the development of a new managed care program, the companies will seek to more efficiently address patient care needs, mental as well as physical. This “whole health approach” will be supported by care coordination, health coaching and support, as well as data analytics, effectively combining the offerings of the companies.

The new care plan is expected to impact 1 million patients from Carelon's 30 clinics and beyond, as patients from MPG and Apree join, Elevance said. 

“We know that when primary care providers are resourced and empowered, they guide consumers through some of life’s most vulnerable moments, while helping people to take control of their own health,” Bryony Winn, president of health solutions at Elevance says in the announcement. “By bringing a new model of advanced primary care to markets across the country, our partnership with CD&R will create a win-win for consumers and care providers alike.”

The specific terms of the financial agreement were not disclosed. However, Elevance aid it will be investing in the CD&R companies through a combination of cash and equity from Carleon.

This week, Elevance’s stock rose 4.7% when the company reported a higher-than-expected “operating gain” of $2.3 billion.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The scheme took place over a period of at least seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.